Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Takashi Miyakoshi

Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma

Cancer Science

English

Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution

Acta Histochemica et Cytochemica

English

Related publications

HLA-A24 and Survivin: Possibilities in Therapeutic Vaccination Against Cancer

Journal of Translational Medicine

English

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)

English

Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer

Journal of Translational Medicine

English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology

English

Randomized Phase II Trial Designs With Biomarkers

Journal of Clinical Oncology

English

Erratum To: Phase I Clinical Trial of Vaccination With URLC10-derived Peptide for Patients With Advanced Esophageal Cancer

Esophagus

Gastroenterology

2012

English

Phase II Trial of Vatalanib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma After First-Line Gemcitabine Therapy (PCRT O4-001)

Cancer Chemotherapy and Pharmacology

English

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Clinical Cancer Research

Cancer Research

Oncology

2011

English

Identification of a Novel HLA-A24-restricted Cytotoxic T Lymphocyte Epitope Peptide Derived From Mesothelin in Pancreatic Cancer

Oncotarget

Oncology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Takashi Miyakoshi

Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma

Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution

Related publications

HLA-A24 and Survivin: Possibilities in Therapeutic Vaccination Against Cancer

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Randomized Phase II Trial Designs With Biomarkers

Erratum To: Phase I Clinical Trial of Vaccination With URLC10-derived Peptide for Patients With Advanced Esophageal Cancer

Phase II Trial of Vatalanib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma After First-Line Gemcitabine Therapy (PCRT O4-001)

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Identification of a Novel HLA-A24-restricted Cytotoxic T Lymphocyte Epitope Peptide Derived From Mesothelin in Pancreatic Cancer